Madrigal Pharmaceuticals Inc (MDGL) Stock Analysis

Madrigal Pharmaceuticals Inc (MDGL) is a publicly traded company in the HEALTHCARE sector. It carries a market capitalization of $10.96B. This page summarizes the public market data, fundamentals, and frequently asked questions for MDGL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Market Cap: $10.96B
• EPS: $-13.51
• 52-Week High: $615.00
• 52-Week Low: $275.00

Market Sentiment

Madrigal Pharmaceuticals Inc currently has a Neutral sentiment score of 0.08.

GNG Research Analysis

GNG Research scores Madrigal Pharmaceuticals Inc (MDGL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MDGL.

Frequently Asked Questions

Does MDGL pay dividends?

Madrigal Pharmaceuticals Inc (MDGL) does not currently pay a regular dividend.